Paul McBarron

Insider Reports History

Entity
Individual
Location
C/O Cyclacel Pharmaceuticals, Inc., 200 Connell Drive, Suite 1500, Berkeley Heights, NJ
Signature
/s/ Paul McBarron
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul McBarron:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cyclacel Pharmaceuticals, Inc. E. VP, Fin, CFO, COO and Secretary, Director Common Stock 33.4K $111K $3.32 Dec 21, 2023 Direct
Cyclacel Pharmaceuticals, Inc. E. VP, Fin, CFO, COO and Secretary, Director Stock Option (right to buy) 70.2K Jun 30, 2023 Direct
Cyclacel Pharmaceuticals, Inc. E. VP, Fin, CFO, COO and Secretary, Director Warrants (right to buy) 1.89K Dec 21, 2023 Direct

Insider Reports Filed by Paul McBarron

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CYCC Cyclacel Pharmaceuticals, Inc. Dec 21, 2023 2 $6.25K 4 Dec 26, 2023 E. VP, Fin, CFO, COO and Secretary, Director
CYCC Cyclacel Pharmaceuticals, Inc. Jun 30, 2023 1 $0 4 Jul 3, 2023 E. VP, Fin, CFO, COO and Secretary, Director
CYCC Cyclacel Pharmaceuticals, Inc. Jan 31, 2023 1 $0 4 Feb 2, 2023 E. VP, Fin, CFO, COO and Secretary, Director
CYCC Cyclacel Pharmaceuticals, Inc. Dec 13, 2021 1 $0 4 Dec 15, 2021 E. VP, Fin, CFO, COO and Secretary, Director